MELD—Moving steadily towards equality, equity, and fairness

作者: James Neuberger , Douglas Thorburn

DOI: 10.1002/LT.20395

关键词: Liver transplantationInternal medicineMedicineChronic liver diseaseOrgan procurementReceiver operating characteristicMortality rateCohortCreatinineSurgeryLiver disease

摘要: Background and aims: A consensus has been reached that liver donor allocation should be based primarily on disease severity waiting time not a major determining factor. Our aim was to assess the capability of Model for End-Stage Liver Disease (MELD) score correctly rank potential recipients according their mortality risk OPTN list. Methods: The MELD model predicts serum creatinine, total bilirubin, INR shown useful in predicting patients with compensated decompensated cirrhosis. In this study, we prospectively applied estimate 3-month 3437 adult transplant candidates chronic who were added list at 2A or 2B status between November, 1999, December, 2001. Results: study cohort disease, 412 (12%) died during follow-up period. Waiting increased directly proportion listing score. Patients having =40 had rate 71.3%. Using c-statistic as end point, area under receiver operating characteristic (ROC) curve 0.83 compared 0.76 Child-Turcotte-Pugh (CTP) (P < 0.001). Conclusions: These data suggest is able accurately predict among can livers.(Gastroenterology 2003;124:91–96.) Context: Endstage serves basis distribution deceased-donor (DD) livers developed response “the final rule” mandate, whose stated principle allocate patient's medical need, less emphasis keeping organs local procurement area. However, selected areas United States, are kept organ organizations (OPOs) small lists transplanted into less-sick instead being allocated sicker nearby centers OPOs large lists. Objective: To determine whether there difference scores receiving transplants vs OPOs. Design setting: Retrospective review US Scientific Registry Transplant Recipients February 28, 2002, March 31, 2003. (N = 4798) end-stage received DD livers. Main outcome measures: (range, 6–40), graft survival, patient survival ( =100 list) RESULTS: same OPOs; 92% 18 less, 7% 19 24, only 2% listed higher than 24 .85). significantly lower (19% 49%; P 24). This disparity does reflect goals current policy, which distribute (JAMA 2004;291:1871–1874.)

参考文章(12)
Chris J. Rudge, Susan V. Fuggle, Kerri M. Burbidge, Geographic disparities in access to organ transplantation in the United Kingdom. Transplantation. ,vol. 76, pp. 1395- 1398 ,(2003) , 10.1097/01.TP.0000090436.01712.20
Anastasios A. Mihas, Anastasios A. Mihas, R. Todd Stravitz, Robert A. Fisher, Leslie M. Williams, Adil Habib, Adil Habib, Arun J. Sanyal, Douglas M. Heuman, Douglas M. Heuman, Souheil G. Abou-Assi, Souheil G. Abou-Assi, Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death Hepatology. ,vol. 40, pp. 802- 810 ,(2004) , 10.1002/HEP.20405
Michael D. Voigt, Bridget Zimmerman, Daniel A. Katz, Stephen C. Rayhill, New national liver transplant allocation policy: Is the regional review board process fair? Liver Transplantation. ,vol. 10, pp. 666- 674 ,(2004) , 10.1002/LT.20116
Russell H. Wiesner, Richard B. Freeman, David C. Mulligan, Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy Gastroenterology. ,vol. 127, pp. 261- 267 ,(2004) , 10.1053/J.GASTRO.2004.09.040
Randolph L. Schaffer, Sanjay Kulkarni, Ann Harper, J. Michael Millis, David C. Cronin, The sickest first? Disparities with model for end-stage liver disease-based organ allocation: One region[apos ]s experience Liver Transplantation. ,vol. 9, pp. 1211- 1215 ,(2003) , 10.1053/JLTS.2003.50192
Jeremy Chapman, Graeme Russ, Geographic variance in access to renal transplantation in Australia. Transplantation. ,vol. 76, pp. 1403- 1406 ,(2003) , 10.1097/01.TP.0000090282.97351.04
B. Miranda, J. Ca????n, N. Cuende, G. Garrido, M. T. Naya, E. Fern??ndez-Zincke, Disparities in access to liver transplantation in Spain. Transplantation. ,vol. 76, pp. 1398- 1403 ,(2003) , 10.1097/01.TP.0000090283.77172.F2
Richard B. Freeman, Mortality risk versus other endpoints: who should come first on the liver transplant waiting list? Liver Transplantation. ,vol. 10, pp. 675- 677 ,(2004) , 10.1002/LT.20103
Fran??oise Roudot-Thoraval, Philippe Romano, Francis Spaak, Didier Houssin, Isabelle Durand-Zaleski, Geographic disparities in access to organ transplant in France. Transplantation. ,vol. 76, pp. 1385- 1388 ,(2003) , 10.1097/01.TP.0000090284.25513.CE
James F. Trotter, Brad Brimhall, Russ Arjal, Charles Phillips, Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation Liver Transplantation. ,vol. 10, pp. 995- 1000 ,(2004) , 10.1002/LT.20195